Growth In Aging Population Offers New Opportunities For Successful China ...

16-10-2013 ForbesComments (0)


Until September Sino Biopharmaceutical of Beijing hadn't been much affected by a year of controversy in China's pharmaceutical industry. GSK of Britain took the brunt of a government probe into the payment of doctors in exchange for prescribing its drugs.

Read more on Forbes

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top